Stay updated on Ph+ AML/CML Clinical Trial: Azacitidine, Venetoclax, Flumatinib
Sign up to get notified when there's something new on the Ph+ AML/CML Clinical Trial: Azacitidine, Venetoclax, Flumatinib page.

Latest updates to the Ph+ AML/CML Clinical Trial: Azacitidine, Venetoclax, Flumatinib page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe record history now includes a new site release note 'Revision: v3.3.3' and removes the earlier release note 'Revision: v3.3.2' as well as the 'HHS Vulnerability Disclosure' entry from the footer. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check41 days agoChange DetectedA new revision entry v3.3.2 was added and the old v3.2.0 entry was removed from the record history. This is a minor update to the study record page.SummaryDifference0.1%

- Check48 days agoChange DetectedThe government funding/operating status notice was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check62 days agoChange DetectedVersion 2 added Study Status and Study Design. Version 3 added Recruitment Status with ongoing updates to Study Status and Study Design.SummaryDifference0.1%

- Check91 days agoChange Detected- Added a government operating status notice and a version bump to v3.2.0. - Removed the old version tag v3.1.0.SummaryDifference13%

- Check98 days agoChange DetectedChanged the revision from v3.0.2 to v3.1.0, indicating a minor version update with no other content changes.SummaryDifference0.3%

Stay in the know with updates to Ph+ AML/CML Clinical Trial: Azacitidine, Venetoclax, Flumatinib
Enter your email address, and we'll notify you when there's something new on the Ph+ AML/CML Clinical Trial: Azacitidine, Venetoclax, Flumatinib page.